Evidence map›Paper›PMID 33983116›Full record

ArticleeLife2021

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease.

Alexa Pichet Binette, Guillaume Theaud, François Rheault, Maggie Roy, D Louis Collins, Johannes Levin, Hiroshi Mori, Jae Hong Lee, Martin Rhys Farlow, Peter Schofield and 12 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 13 institutions in 7 countries.

Alexa Pichet BinetteDepartment of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada.ORCID 0000-0001-5218-3337
Guillaume TheaudSherbrooke Connectivity Imaging Laboratory (SCIL), Université de Sherbrooke, Sherbrooke, Canada.
François RheaultElectrical Engineering, Vanderbilt University, Nashville, United States.
Maggie RoySherbrooke Connectivity Imaging Laboratory (SCIL), Université de Sherbrooke, Sherbrooke, Canada.
D Louis CollinsMcConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Canada.ORCID 0000-0002-8432-7021
Johannes LevinDepartment of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
Hiroshi MoriDepartment of Clinical Neuroscience, Osaka City University Medical School, Osaka, Japan.
Jae Hong LeeDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Martin Rhys FarlowDepartment of Neurology, Indiana University, Bloomington, United States.
Peter SchofieldNeuroscience Research Australia, Sydney, Australia.
Jasmeer P ChhatwalHarvard Medical School, Massachusetts General Hospital, Boston, United States.
Colin L MastersThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.
Tammie BenzingerKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, United States.
John MorrisKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, United States.
Randall BatemanKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, United States.
John Cs BreitnerDepartment of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada.
Judes PoirierDepartment of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada.
Julie GonneaudDouglas Mental Health University Institute, Montreal, Canada.
Maxime DescoteauxSherbrooke Connectivity Imaging Laboratory (SCIL), Université de Sherbrooke, Sherbrooke, Canada.
Sylvia VilleneuveDepartment of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada.
DIAN Study Group
PREVENT-AD Research Group
Douglas Mental Health University Institute · CAUniversité de Sherbrooke · CAWashington University in St. Louis · USMontreal Neurological Institute and Hospital · CAGerman Center for Neurodegenerative Diseases · DEHarvard University · USIndiana University Bloomington · USInserm · FROsaka City University · JPThe University of Melbourne · AUUlsan College · KRUNSW Sydney · AUVanderbilt University · US

Funding

Imaging CoreU19AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2010 to 2025
$53.9M
Dominantly Inherited Alzheimer NetworkUF1AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2014 to 2017
$21.6M
Imaging CoreU01AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2008 to 2009
$6.1M
CIHR PJT-148963CIHR PJT-162091NIA NIH HHS U01 AG032438NIA NIH HHS U19 AG032438NIA NIH HHS UF1 AG032438
6 · The paper itself

Abstract

Beta-amyloid (Aβ) and tau proteins, the pathological hallmarks of Alzheimer's disease (AD), are believed to spread through connected regions of the brain. Combining diffusion imaging and positron emission tomography, we investigated associations between white matter microstructure specifically in bundles connecting regions where Aβ or tau accumulates and pathology. We focused on free-water-corrected diffusion measures in the anterior cingulum, posterior cingulum, and uncinate fasciculus in cognitively normal older adults at risk of sporadic AD and presymptomatic mutation carriers of autosomal dominant AD. In Aβ-positive or tau-positive groups, lower tissue fractional anisotropy and higher mean diffusivity related to greater Aβ and tau burden in both cohorts. Associations were found in the posterior cingulum and uncinate fasciculus in preclinical sporadic AD, and in the anterior and posterior cingulum in presymptomatic mutation carriers. These results suggest that microstructural alterations accompany pathological accumulation as early as the preclinical stage of both sporadic and autosomal dominant AD.

Indexed as

AdultAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesDiffusion Tensor ImagingFemaleHumansMaleMiddle AgedPositron-Emission Tomographytau ProteinsWhite MatterAmyloid beta-Peptidestau Proteinscingulumdiffusion MRIfree-waterhumanneurosciencePETuncinate fasciculus

Identifiers

PMID33983116
PMCPMC8169107
OpenAlexW3161462824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.